197 related articles for article (PubMed ID: 26355706)
1. Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.
Sjöberg B; Qureshi AR; Heimbürger O; Stenvinkel P; Lind L; Larsson A; Bárány P; Ärnlöv J
J Intern Med; 2016 Feb; 279(2):173-9. PubMed ID: 26355706
[TBL] [Abstract][Full Text] [Related]
2. Endostatin level is associated with kidney injury in the elderly: findings from two community-based cohorts.
Ruge T; Carlsson AC; Larsson TE; Carrero JJ; Larsson A; Lind L; Ärnlöv J
Am J Nephrol; 2014; 40(5):417-24. PubMed ID: 25401956
[TBL] [Abstract][Full Text] [Related]
3. Use of Proteomics To Investigate Kidney Function Decline over 5 Years.
Carlsson AC; Ingelsson E; Sundström J; Jesus Carrero J; Gustafsson S; Feldreich T; Stenemo M; Larsson A; Lind L; Ärnlöv J
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1226-1235. PubMed ID: 28784837
[TBL] [Abstract][Full Text] [Related]
4. The association between glomerular filtration rate and left ventricular function in two independent community-based cohorts of elderly.
Nerpin E; Ingelsson E; Risérus U; Sundström J; Andren B; Jobs E; Larsson A; Lars L; Ärnlöv J
Nephrol Dial Transplant; 2014 Nov; 29(11):2069-74. PubMed ID: 24916339
[TBL] [Abstract][Full Text] [Related]
5. Soluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly Individuals.
Carlsson AC; Nordquist L; Larsson TE; Carrero JJ; Larsson A; Lind L; Ärnlöv J
Cardiorenal Med; 2015 Oct; 5(4):278-88. PubMed ID: 26648944
[TBL] [Abstract][Full Text] [Related]
6. Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease.
Nishi K; Imamura T; Kitamura K; Ogawa T; Fujimoto S; Kakitsubata Y; Ishikawa T; Asada Y; Kodama T
Ren Fail; 2011; 33(4):398-404. PubMed ID: 21529268
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for chronic kidney diseases may include periodontal diseases, as estimated by the correlations of plasma pentraxin-3 levels: a case-control study.
Pradeep AR; Kathariya R; Arjun Raju P; Sushma Rani R; Sharma A; Raghavendra NM
Int Urol Nephrol; 2012 Jun; 44(3):829-39. PubMed ID: 21637988
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss.
Witasp A; Carrero JJ; Michaëlsson K; Ahlström H; Kullberg J; Adamsson V; Risérus U; Larsson A; Helmersson-Karlqvist J; Lind L; Stenvinkel P; Arnlöv J
Obesity (Silver Spring); 2014 May; 22(5):1373-9. PubMed ID: 24415446
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.
Dubin R; Shlipak M; Li Y; Ix J; de Boer IH; Jenny N; Peralta CA
Nephrol Dial Transplant; 2011 Jun; 26(6):1903-8. PubMed ID: 21079193
[TBL] [Abstract][Full Text] [Related]
10. The relationship between IL-10 levels and cardiovascular events in patients with CKD.
Yilmaz MI; Solak Y; Saglam M; Cayci T; Acikel C; Unal HU; Eyileten T; Oguz Y; Sari S; Carrero JJ; Stenvinkel P; Covic A; Kanbay M
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1207-16. PubMed ID: 24789549
[TBL] [Abstract][Full Text] [Related]
11. Serum fatty acid patterns, insulin sensitivity and the metabolic syndrome in individuals with chronic kidney disease.
Huang X; Sjögren P; Ärnlöv J; Cederholm T; Lind L; Stenvinkel P; Lindholm B; Risérus U; Carrero JJ
J Intern Med; 2014 Jan; 275(1):71-83. PubMed ID: 24011327
[TBL] [Abstract][Full Text] [Related]
12. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.
Peralta CA; Shlipak MG; Judd S; Cushman M; McClellan W; Zakai NA; Safford MM; Zhang X; Muntner P; Warnock D
JAMA; 2011 Apr; 305(15):1545-52. PubMed ID: 21482744
[TBL] [Abstract][Full Text] [Related]
13. Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.
Yilmaz MI; Sonmez A; Ortiz A; Saglam M; Kilic S; Eyileten T; Caglar K; Oguz Y; Vural A; Çakar M; Egido J; Altun B; Yenicesu M; Blanco-Colio LM; Carrero JJ
Clin J Am Soc Nephrol; 2011 Apr; 6(4):785-92. PubMed ID: 21330486
[TBL] [Abstract][Full Text] [Related]
14. Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.
Dubin R; Li Y; Ix JH; Shlipak MG; Whooley M; Peralta CA
Am Heart J; 2012 Feb; 163(2):274-9. PubMed ID: 22305847
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
Ji E; Kim YS
Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
[TBL] [Abstract][Full Text] [Related]
16. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study.
Lee R; Shin MH; Kim HN; Lee YH; Choi SW; Ahn HR; Kweon SS
Int Urol Nephrol; 2017 Nov; 49(11):2027-2033. PubMed ID: 28733767
[TBL] [Abstract][Full Text] [Related]
18. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
Shardlow A; McIntyre NJ; Fraser SDS; Roderick P; Raftery J; Fluck RJ; McIntyre CW; Taal MW
PLoS Med; 2017 Oct; 14(10):e1002400. PubMed ID: 29016597
[TBL] [Abstract][Full Text] [Related]
19. Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.
Witasp A; Rydén M; Carrero JJ; Qureshi AR; Nordfors L; Näslund E; Hammarqvist F; Arefin S; Kublickiene K; Stenvinkel P
PLoS One; 2013; 8(5):e63493. PubMed ID: 23658833
[TBL] [Abstract][Full Text] [Related]
20. The association of angiogenic factors and chronic kidney disease.
Anderson CE; Hamm LL; Batuman G; Kumbala DR; Chen CS; Kallu SG; Siriki R; Gadde S; Kleinpeter MA; Krane NK; Simon EE; He J; Chen J
BMC Nephrol; 2018 May; 19(1):117. PubMed ID: 29783932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
